NYSE:CORHealthcare
Cencora (COR) Posts Strong Q3 Earnings, Is The 9% Upside Enough?
Cencora (COR) drew investor attention after reporting third quarter 2026 results, highlighting higher sales, net income and earnings per share, along with ongoing share repurchases and a fresh quarterly dividend declaration.
See our latest analysis for Cencora.
Cencora's recent earnings, dividend declaration and larger revolving credit facility sit against a mixed share price picture, with the stock at US$320.46 and showing a 22.81% 90 day share price return but a decline of 5.43% year to...